News

                        Array
(
    [0] => stdClass Object
        (
            [id] => 1407
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => eurofins-gentis-thong-bao-lam-việc-xuyen-tết-nguyen-Đan-2026.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2026-02-06
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-02-06 08:43:25
            [updated_time] => 2026-02-09 08:31:17
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-announces-continuous-operations-throughout-Lunar-New-Year-2026
            [title] => Eurofins GENTIS announces continuous operations throughout Lunar New Year 2026
            [description] => Lunar New Year is a sacred moment, marking the close of an old year and the beginning of a new journey filled with hope, renewal, and success. It is also a time for people to temporarily set aside work and reunite with family and loved ones.
            [content] => 
Understanding this special significance, and driven by professional responsibility and a long-term commitment to accompany our clients and partners, Eurofins GENTIS respectfully announces that we will maintain continuous operations throughout the Lunar New Year 2026 to ensure service progress, quality, and timely response to the needs of our valued partners, customers, and experts nationwide.
A commitment to uninterrupted support
In the field of genetic testing and high-tech scientific services, time and accuracy play an extremely important role. Many customers, partners, and experts require continuous services, even during special periods such as the Lunar New Year. Therefore, maintaining operations during the holiday not only demonstrates operational flexibility but also reflects Eurofins GENTIS’s strong commitment to putting customer interests and experience at the center.
Working throughout the Lunar New Year helps to ensure:


No interruption in sample reception, processing, and result reporting


Timely support for urgent requests


Continuous connection between Eurofins GENTIS and partners and customers


Optimized work progress from the very first days of the new year



Scope and working arrangements during Lunar New Year 2026
During Lunar New Year 2026, Eurofins GENTIS will maintain on-duty teams to ensure stable operation of core activities. Professional departments, consulting, and customer support teams will operate according to pre-arranged plans, flexibly while strictly complying with professional procedures and global Eurofins quality standards.
Eurofins GENTIS’s main communication channels will remain active, ready to receive information, provide consultation, and handle customer requests throughout the holiday. This reflects our strong sense of responsibility, professionalism, and thorough preparation to bring absolute peace of mind to customers using our services.
Proactive actions for the benefit of partners and customers
Choosing to operate throughout the Lunar New Year is not only an operational decision but also a strategy aimed at sustainable development and long-term partnerships. Eurofins GENTIS understands that for many partners and customers, work does not pause according to holiday schedules, but instead requires timely, accurate, and well-coordinated support.
Therefore, Eurofins GENTIS strives to:


Remain a reliable companion, even during peak periods


Support partners in maintaining professional, research, and operational plans


Enable customers to be more proactive in arranging their schedules and work


Appreciation for the Eurofins GENTIS team
Behind the decision to work through the Lunar New Year is the quiet dedication and strong sense of responsibility of Eurofins GENTIS employees. Despite this being an important traditional holiday, many GENTISers are willing to remain at their posts to ensure smooth, safe, and efficient operations.
Eurofins GENTIS always recognizes and values these contributions, as the team’s dedication, professionalism, and unity form a solid foundation for sustainable growth and continuous service improvement.
New Year appreciation and wishes
As Lunar New Year 2026 approaches, Eurofins GENTIS would like to express our sincere and heartfelt thanks to our valued partners, customers, and experts who have trusted, chosen, and accompanied us over the past time. Your support and cooperation are powerful motivations for Eurofins GENTIS to continuously improve and grow.
Entering the new year 2026, Eurofins GENTIS looks forward to continuing to accompany you on new journeys with more opportunities, success, and sustainable value.
Wishing our valued partners, customers, and their families a New Year of Health, Prosperity, and Fulfillment.
Eurofins GENTIS is always ready to accompany, serve, and dedicate — even during the days of Tet reunion.
            [content_more] => 
            [meta_title] => Eurofins GENTIS announces continuous operations throughout Lunar New Year 2026
            [meta_description] => Lunar New Year is a sacred moment, marking the close of an old year and the beginning of a new journey filled with hope, renewal, and success. It is also a time for people to temporarily set aside work and reunite with family and loved ones.
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1407
            [category_id] => 4
        )

    [1] => stdClass Object
        (
            [id] => 1406
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => img_4684.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2026-02-06
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-02-06 08:41:18
            [updated_time] => 2026-02-07 09:25:41
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS's-year-end-party-2025-United-as-one-steadfast-forward
            [title] => Eurofins GENTIS's year end party 2025 - United as one, steadfast forward
            [description] => Eurofins GENTIS solemnly hosted the Year End Party 2025 with the theme “United as One, Steadfast Forward.” The event was not only an occasion to review and reflect on a year of development, but also a meaningful space for connection, where the entire Eurofins GENTIS family gathered, shared, and spread the spirit of unity and determination toward the future.
            [content] => 
Year End Party 2025 took place in an atmosphere that was both formal and warm, vibrant yet heartfelt, leaving many emotions and lasting impressions on every employee, partner, and expert in attendance.

Looking back at 2025 – A  year of effort and achievement
The year 2025 marked a period of strong growth for Eurofins GENTIS with many important milestones. The achievements were not only reflected in growth figures, but also in improvements in service quality, brand reputation, and the professional working spirit of the entire team.
The Year End Party was an opportunity for the Eurofins GENTIS collective to look back on that journey — a journey built on perseverance, responsibility, and unity from every individual. Each member, in different roles, contributed to a proud overall picture that reflects the company’s sustainable development.

Eurofins GENTIS highly appreciates and values the presence of our esteemed partners and experts at the Year End Party 2025. Their attendance was not only an honor, but also a testament to the strong, trustworthy, and long-term partnerships between Eurofins GENTIS and its collaborators.
The trust and support from our partners and experts have played a vital role in the successes Eurofins GENTIS achieved throughout 2025. The party was an occasion for all sides to reflect on the journey so far, while opening new expectations for deeper and more effective cooperation in the future.

One of the most memorable and emotional moments of the program was the group photo of Eurofins GENTIS employees together with partners and experts. In a space filled with joy and pride, every smile and every glance reflected unity, connection, and confidence in the road ahead.
The photo not only captured a moment, but also became a symbol of the message “United as One, Steadfast Forward” — when everyone shares the same goals, looks toward the future, and is ready to work together to build a stronger Eurofins GENTIS.

At the Year End Party 2025, Mr. Do Manh Ha – General Director of Eurofins GENTIS — delivered an important speech sharing the company’s outstanding achievements in 2025. These results clearly demonstrate the right strategies, the determination of the leadership team, and the tireless efforts of all employees.
In addition to reflecting on the past year, the General Director also affirmed the vision, goals, and development directions for 2026, with expectations to further improve service quality, expand cooperation, and strengthen Eurofins GENTIS’s position in its field of expertise. His sharing was not only strategic in orientation but also highly inspiring, motivating the entire team to enter the new year with greater confidence and determination.

A meaningful and significant part of the Year End Party 2025 was the ceremony honoring outstanding individuals and teams. These were the faces that made remarkable contributions, demonstrating responsibility, creativity, and continuous effort throughout the year.






Each name called was a story of dedication, a testament to wholehearted commitment and the aspiration to grow. The enthusiastic applause was not only well-deserved recognition but also a great source of encouragement, spreading positivity and promoting a culture of recognition and appreciation at Eurofins GENTIS.
After the formal moments, the program moved into the year-end banquet in a lively, cozy, and joyful atmosphere. New Year wishes and shared stories helped erase distances and brought members closer together.
Additionally, awards for outstanding activities and contributions were not only a form of recognition but also motivation for all employees to continue being creative, striving, and accompanying Eurofins GENTIS on its development journey ahead.







An indispensable part of the Year End Party 2025 was the exciting Lucky Draw. The suspenseful waiting moments and the bursts of cheers when attractive prizes found their winners made the atmosphere even more energetic.
More than just prizes, the Lucky Draw was an occasion for everyone to share joy, create memorable moments, and strengthen the bonds among members of the Eurofins GENTIS family.
Closing a memorable year, ready for a new journey
Year End Party 2025 – “United as One, Steadfast Forward” concluded in a joyful, warm, and emotional atmosphere. The year 2025 left many proud marks, serving as a strong foundation for Eurofins GENTIS to enter 2026 with greater confidence, ambition, and determination.

With a spirit of unity, solidarity, and continuous effort from the entire team, Eurofins GENTIS will continue moving forward together, reaching new heights and building a more sustainable and brilliant future in the years to come.
            [content_more] => 
            [meta_title] => Eurofins GENTIS's year end party 2025 - United as one, steadfast forward
            [meta_description] => Eurofins GENTIS solemnly hosted the Year End Party 2025 with the theme “United as One, Steadfast Forward.” The event was not only an occasion to review and reflect on a year of development, but also a meaningful space for connection, where the entire Euro
            [meta_keyword] => GENTIS,YEAR END PARTY
            [thumbnail_alt] => 
            [post_id] => 1406
            [category_id] => 4
        )

    [2] => stdClass Object
        (
            [id] => 1405
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => z7475342255361_6d2a37fa1d1528705dc55057db6a4222.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 0000-00-00
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-01-29 13:20:52
            [updated_time] => 2026-01-30 13:30:18
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-and-Phenikaa-hospital-strengthen-professional-exchange-on-preimplantation-genetic-testing
            [title] => Eurofins GENTIS and Phenikaa hospital strengthen professional exchange on preimplantation genetic testing
            [description] => In recent years, alongside in vitro fertilization (IVF), preimplantation genetic testing (PGT) solutions have increasingly been recognized as a key factor in improving success rates, minimizing risks, and working toward the goal of delivering healthy babies. Scientifically guided embryo selection plays a crucial role in helping clinicians and patients make safer and more effective decisions in each treatment cycle.
            [content] => 

Responding to the growing demand for the application of PGT solutions in assisted reproduction, Eurofins GENTIS recently collaborated with Phenikaa Hospital to organize a professional working session. The meeting focused on exchanging insights and updating advanced genetic testing solutions currently applied in reproductive medicine, including specialized technologies and services developed and implemented by Eurofins GENTIS.
Representing Eurofins GENTIS, Dr. Nguyen Quang Vinh (Laboratory Director) directly presented and reported on the professional content at the session. On the Phenikaa Hospital side, the meeting was attended by a team of physicians, specialists, and technicians in assisted reproduction, who engaged in in-depth discussions on the practical application of genetic testing in IVF treatment.

At the meeting, Dr. Vinh provided an overview of the PGT testing system currently implemented at Eurofins GENTIS, with a focus on PGT-A/SR—preimplantation genetic testing for aneuploidies and structural rearrangements. PGT-A/SR enables comprehensive analysis of all 24 chromosomes, detecting numerical and structural abnormalities, including aneuploidy, deletions, duplications, and mosaicism. The application of PGT-A/SR helps IVF clinicians select embryos with higher implantation potential, reduce the risk of early miscarriage, and increase embryo transfer success rates, particularly in advanced-age patients, those with repeated IVF failures, or a history of pregnancy loss. Data shared by Eurofins GENTIS showed that embryos with chromosomal abnormalities account for nearly half of all analyzed samples. This highlights the importance of preimplantation genetic testing, as many embryos with good morphology may still harbor underlying genetic abnormalities that can directly affect pregnancy outcomes if not screened early.
In addition to PGT-A/SR, PGT-M was another topic of particular interest to Phenikaa Hospital. This solution is designed for couples who carry genes associated with inherited diseases but wish to have healthy children free from these conditions. Eurofins GENTIS has currently implemented more than 100 PGT-M protocols for a wide range of conditions such as thalassemia, spinal muscular atrophy (SMA), hemophilia, and other rare genetic disorders, using advanced technologies including next-generation sequencing (NGS), STR, SNP analysis, and karyomapping. The integration of PGT-M with IVF helps prevent genetic diseases at the embryo stage, delivering long-term benefits for the health of future generations.
Within the framework of the session, Dr. Vinh also highlighted Eurofins GENTIS’s testing capacity and internationally standardized laboratory system, featuring the Illumina MiSeq NGS platform and specialized analysis software BlueFuse. Notably, the achievement of CAP accreditation for PGT testing serves as strong evidence of quality, reliability, and standardization across the entire genetic testing workflow at GENTIS.
Beyond introducing genetic testing services and modern laboratory infrastructure, Dr. Nguyen Quang Vinh also directly addressed professional questions from Phenikaa Hospital’s experts and physicians, helping clarify practical issues related to the application of genetic testing in assisted reproduction. Physicians at Phenikaa Hospital highly appreciated the professional insights, real-world data, and testing solutions provided by Eurofins GENTIS, considering them an important foundation for improving treatment outcomes and the quality of care for IVF patients.
The professional exchange between Eurofins GENTIS and Phenikaa Hospital not only held academic value but also opened up directions for sustainable collaboration in training, clinical consultation, and the implementation of advanced genetic testing solutions. Through close cooperation, both parties expect to contribute to improving IVF treatment effectiveness, reducing the psychological and financial burden on patients, and delivering meaningful value to the community in the journey toward fulfilling the dream of having healthy children.
            [content_more] => 
            [meta_title] => Eurofins GENTIS and Phenikaa hospital strengthen professional exchange on preimplantation genetic te
            [meta_description] => In recent years, alongside in vitro fertilization (IVF), preimplantation genetic testing (PGT) solutions have increasingly been recognized as a key factor in improving success rates, minimizing risks, and working toward the goal of delivering healthy babi
            [meta_keyword] => GENTIS,Phenikaa
            [thumbnail_alt] => 
            [post_id] => 1405
            [category_id] => 4
        )

    [3] => stdClass Object
        (
            [id] => 1404
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => rabbit_media-4214.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2026-01-23
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-01-23 10:43:46
            [updated_time] => 2026-01-30 13:27:57
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Trends-and-applications-of-AI-and-omics-data-in-genetic-testing-and-reproductive-genetic-counseling
            [title] => Trends and applications of AI and omics data in genetic testing and reproductive genetic counseling
            [description] => In recent years, artificial intelligence (AI) has emerged as one of the key driving forces behind the technological revolution across many fields, especially healthcare. From medical imaging diagnostics and chronic disease management to drug research and development, AI has demonstrated its pivotal role in improving treatment effectiveness and personalizing healthcare. In the field of genetics and assisted reproduction, the integration of AI, bioinformatics, and Omics data is expected to create major breakthroughs, significantly enhancing the quality of screening, diagnosis, and genetic counseling.
            [content] => 
AI and omics data – The foundation of precision medicine
 The rapid development of next-generation sequencing (NGS), mass spectrometry technologies, along with the increasing capacity for collecting and storing large-scale clinical data, has generated an enormous volume of information in medical genetics. Omics data—including genomics, transcriptomics, proteomics (proteins and post-translational modifications), metabolomics (metabolites and hormones), together with bioinformatics and AI—provide a comprehensive reflection of biological characteristics at the molecular level. However, analyzing and effectively exploiting these datasets poses a major challenge if relying solely on traditional methods.
Dr. Pham Dinh Minh (R&D Director, Eurofins GENTIS) presenting at the Symposium on Reproductive Genetics and PGT
With its machine learning capabilities and multidimensional data analysis, AI enables rapid and accurate processing of complex Omics datasets, thereby uncovering potential relationships among genetic factors, clinical data, and disease risks. In assisted reproduction, this opens up opportunities to improve embryo screening quality, predict implantation potential, and provide more scientific and personalized genetic risk counseling for couples.
Eurofins GENTIS pioneers the application of AI in reproductive genetics
 According to Dr. Pham Dinh Minh (R&D Director of Eurofins GENTIS) at the Symposium on Reproductive Genetics and PGT, in recent years Eurofins GENTIS has focused on developing information technology platforms and AI applications integrated with Omics data to support genetic screening, counseling, and management of hereditary diseases. These solutions not only provide professional support for hospitals and partners but also strengthen the connection between Eurofins GENTIS, clinicians, healthcare facilities, and patients, contributing to improved user experience and healthcare service quality.
In the field of genetic analysis, Eurofins GENTIS has been researching and developing various bioinformatics tools to support the application of AI in studying the molecular mechanisms of fertilization, embryo development, and factors affecting infertility and subfertility. These studies aim to improve the success rates of in vitro fertilization (IVF) and to personalize treatment for each patient in the future.
PGT-AI – A new approach to embryo selection
One of the greatest challenges in IVF today is how to increase pregnancy rates and the likelihood of delivering healthy babies after embryo transfer. According to Dr. Pham Dinh Minh, the embryo is the decisive factor determining the success of an IVF cycle. Selecting the best embryo not only affects implantation rates but also has long-term implications for the child’s future health.
In this context, the application of artificial intelligence in preimplantation genetic testing (PGT-AI) is considered a highly promising trend. PGT-AI goes beyond the assessment of chromosomal abnormalities in embryos and aims to select the “best embryo among good embryos” from a genetic perspective.

Eurofins GENTIS Is researching the application of AI to predict embryo transfer success


Currently, Eurofins GENTIS is conducting pilot studies on applying AI to predict the success potential of embryo transfer. By analyzing the genetic data of embryos in combination with maternal clinical factors, AI can help identify relationships between embryos and their compatibility with the uterine environment. This enables clinicians to make optimal embryo selection decisions, thereby improving implantation rates and overall IVF success.
By integrating maternal clinical data and expanding the analysis of embryonic genetic data within PGT-AI, the research team at Eurofins GENTIS is developing screening and predictive models to identify healthy embryos with high implantation potential. This is regarded as an important step toward personalized counseling and assisted reproductive treatment.
Applications of AI in NIPT and newborn screening
In addition to IVF and PGT-AI, AI is also being strongly applied by Eurofins GENTIS in the fields of prenatal and newborn screening. In non-invasive prenatal testing (NIPT), Eurofins GENTIS collaborates with the University of Engineering and Technology – Vietnam National University, Hanoi, to develop bioinformatics algorithms that expand the detection spectrum of genetic variants. As a result, the sensitivity, accuracy, and specificity of NIPT have been significantly improved, contributing to higher-quality fetal anomaly screening.
Eurofins GENTIS Is researching and applying AI and Information technology in newborn screening
For newborn screening, Eurofins GENTIS is developing AI-integrated software solutions to enhance the detection of complex metabolic disorders based on mass spectrometry data. From these datasets, algorithms are built to support rapid and accurate early prediction and diagnosis of genetic diseases related to metabolic disorders in newborns.
Notably, in the process of reporting results, Eurofins GENTIS has integrated information technology and AI to interpret testing data, helping clinicians and families more easily access disease-related information, understand risks, and determine appropriate treatment directions for infants.
The application of AI and Omics data in genetic testing and counseling is ushering in a new era for assisted reproduction and precision medicine. With ongoing research and real-world applications, Eurofins GENTIS demonstrates its pioneering role in bringing advanced technologies into reproductive healthcare services in Vietnam.
In the future, as datasets become more comprehensive and AI algorithms more refined, AI-based genetic solutions are expected to support clinicians in making more accurate decisions, optimizing treatment outcomes, creating opportunities for parenthood for many infertile couples, and contributing to sustainable improvements in population health.
            [content_more] => 
            [meta_title] => Trends and applications of AI and omics data in genetic testing and reproductive genetic counseling
            [meta_description] => In recent years, artificial intelligence (AI) has emerged as one of the key driving forces behind the technological revolution across many fields, especially healthcare. From medical imaging diagnostics and chronic disease management to drug research and 
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1404
            [category_id] => 4
        )

    [4] => stdClass Object
        (
            [id] => 1403
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => f28d3c7874e6fbb8a2f7.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2026-01-13
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-01-13 16:14:28
            [updated_time] => 2026-01-19 08:30:31
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Warning-of-fraudulent-impersonation-of-Eurofins-GENTIS-requesting-customers-to-transfer-money-for-early-delivery-of-test-results
            [title] => Warning of fraudulent impersonation of Eurofins GENTIS requesting customers to transfer money for early delivery of test results
            [description] => Dear Valued customers and partners,

            [content] => 
Recently, Eurofins GENTIS has received reports from several customers about unknown individuals calling by phone, impersonating company staff, and requesting payment of shipping fees for the delivery of test results (for NIPT tests and newborn screening tests), claiming that the results would be sent directly to the customers’ homes.

In response to this situation, Eurofins GENTIS would like to clearly affirm that the Company does not make phone calls requesting customers to transfer money via telephone or to personal accounts to pay any fees related to the delivery of test results. All service fees (if any) are publicly and transparently communicated at the time of registration and are implemented strictly in accordance with Eurofins GENTIS procedures. At the same time, we do not sell, provide, disclose, or allow the leakage of customers’ personal information in any form.
Currently, Eurofins GENTIS uses only one official customer service hotline: 1800 2010 to contact customers and notify them of test results. Any calls from other phone numbers requesting money transfers or personal information are not from Eurofins GENTIS.
In the context of rapid digital technology development, personal information may be collected from various sources and exploited for fraudulent activities, causing inconvenience and even serious impacts on customers’ rights and property. Therefore, Eurofins GENTIS kindly asks our partners and customers to remain vigilant, not to provide personal information, OTP codes, or bank account details, and not to transfer money without proper verification of the information.
Upon receiving any suspicious calls or unusual information related to test results, partners and customers are kindly requested to contact Eurofins GENTIS directly via the hotline 1800 2010 for timely verification and support.
Eurofins GENTIS sincerely thanks our valued partners and customers for their trust and companionship over the years, and kindly asks everyone to share this information with relatives and the community to help prevent unfortunate risks that may occur.
For further information, please contact:
EUROFINS GENTIS HANOI:
3rd Floor, V+ Shopping Center, 505 Minh Khai, Vinh Tuy Ward, Hanoi
EUROFINS GENTIS HO CHI MINH CITY:
8/24 Nguyen Dinh Khoi, Tan Son Nhat Ward, Ho Chi Minh City
Hotline: 1800 2010
Email: dichvu@gentis.com.vn
Sincerely,
            [content_more] => 
            [meta_title] => Warning of fraudulent impersonation of Eurofins GENTIS requesting customers to transfer money for ea
            [meta_description] => Dear Valued customers and partners,

            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1403
            [category_id] => 4
        )

    [5] => stdClass Object
        (
            [id] => 1400
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 12313.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2026-01-08
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-01-08 15:21:13
            [updated_time] => 2026-01-15 10:03:53
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-honored-to-participate-in-the-reproductive-genetics-PGT-conference-2026
            [title] => Eurofins GENTIS honored to participate in the reproductive genetics & PGT conference 2026
            [description] => On January 18, 2026, at New World Saigon Hotel, Ho Chi Minh City, the Ho Chi Minh City Society of Reproductive Endocrinology & Infertility (HOSREM) – one of the most reputable professional organizations in reproductive medicine in Vietnam – in collaboration with specialized partners, will organize the Reproductive Genetics & PGT Conference.
            [content] => 

For many years, HOSREM has played a pioneering role in connecting the professional community, updating advances in reproductive medicine, and improving the quality of infertility treatment in Vietnam.
This year’s conference continues to serve as a key scientific forum, bringing together leading experts, physicians, and researchers to exchange knowledge, share experiences, and introduce the latest achievements in reproductive genetics, PGT technology, and modern assisted reproduction.
Eurofins introduces its speaker at the conference
At this year’s Reproductive Genetics & PGT Conference, Eurofins GENTIS is honored to present an in-depth scientific presentation, demonstrating its strong commitment to the development of assisted reproductive medicine:
Pham Dinh Minh, PhD (R&D Director, Eurofins GENTIS): “Trends and Applications of AI and Omics Data in Genetic Testing and Counseling for Assisted Reproduction”
With extensive expertise in bioinformatics, genetic technology, and artificial intelligence, Dr. Pham Dinh Minh will present:

Development trends of AI & Omics data in modern reproductive medicine

Applications of AI & Omics in genetic testing and counseling for assisted reproduction

Personalized treatment solutions to enhance clinical effectiveness



Eurofins GENTIS – Main sponsor of the reproductive genetics & PGT conference 2026
Eurofins GENTIS is proud to accompany the Conference as the Main Sponsor, demonstrating its long-term commitment to promoting genetic research and application, and improving the quality of assisted reproductive services in Vietnam.
At the event, the Eurofins GENTIS booth promises to offer many engaging activities for distinguished delegates. It will be a hub for updating the latest testing methods and technologies in assisted reproduction, helping to enhance clinical outcomes for patients.
Visitors will also have the opportunity to engage directly with Eurofins GENTIS’ experienced experts, receive answers regarding testing procedures, and explore the latest technological innovations that Eurofins GENTIS is actively researching and developing.
In addition, the Eurofins GENTIS booth will host exciting minigame activities with many lovely appreciation gifts for conference participants.
Eurofins GENTIS respectfully invites all physicians, specialists, and guests to visit its booth at the Reproductive Genetics & PGT Conference 2026 on:
 

Sunday, January 18, 2026
New World Saigon Hotel, Ho Chi Minh City 

Let us join hands with HOSREM and Eurofins GENTIS in advancing reproductive healthcare quality and creating new opportunities for future families.
We look forward to welcoming you at the Eurofins GENTIS booth.


            [content_more] => 
            [meta_title] => Eurofins GENTIS honored to participate in the reproductive genetics & PGT conference 2026
            [meta_description] => On January 18, 2026, at New World Saigon Hotel, Ho Chi Minh City, the Ho Chi Minh City Society of Reproductive Endocrinology & Infertility (HOSREM) – one of the most reputable professional organizations in reproductive medicine in Vietnam – in collaborati
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1400
            [category_id] => 4
        )

    [6] => stdClass Object
        (
            [id] => 1399
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 28_thể_ẩn.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2025-12-31
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-12-31 14:41:49
            [updated_time] => 2026-01-15 09:59:00
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-launches-GEN28-carrier-screening-test-for-28-recessive-genetic-disorders
            [title] => Eurofins GENTIS launches GEN28 – carrier screening test for 28 recessive genetic disorders
            [description] => On the journey of parenthood, nothing is more important than ensuring a child is born healthy. In reality, many individuals who appear completely healthy may unknowingly carry recessive genetic mutations. When both partners carry the same recessive gene, the risk of having a child affected by serious genetic disorders can be as high as 25%, leading to long-term impacts on health and quality of life.
            [content] => 
Therefore, as a leading institution in the number of recessive carrier screenings, Eurofins GENTIS has researched and developed GEN28 – Screening of 28 Genetic Disease Genes, designed to identify carriers, assess hereditary risks for offspring, and provide personalized genetic counseling—helping families embark on parenthood with maximum peace of mind.

GEN28 Test – screening of 28 recessive genetic disease genes
GEN28 is a screening test for 28 common and severe recessive genetic disease genes, performed using Next Generation Sequencing (NGS) technology. The test detects individuals who carry recessive disease genes. These conditions are often difficult to treat, require long-term care, and have lifelong effects on patients’ health and quality of life. With GEN28, couples can identify genetic risks early and proactively choose safe and healthy reproductive options.

Detection Scope: 28 recessive genetic disease genes
Method: GEN28 is conducted using Next Generation Sequencing (NGS). Sequencing data are processed and analyzed using specialized bioinformatics software.
Sample Type:
- 2–3 ml of whole blood collected in EDTA tubes.
- For patients undergoing GEN28 together with NIPT testing: a single 7–10 ml sample collected in the NIPT tubes currently used at Eurofins GENTIS is sufficient; no additional EDTA tube is required.
Turnaround Time: 8–10 working days

Diseases screened by GEN28
The 28 genes are associated with 25 inherited syndromes and disorders, including:

Alpha thalassemia
Beta thalassemia
Pendred syndrome / DFNB4 non-syndromic hearing loss
G6PD deficiency
Citrin deficiency
Pompe disease
Wilson disease
Phenylketonuria
Classic galactosemia (Type I)
Galactosemia Type II deficiency
Ornithine Transcarbamylase deficiency
Smith-Lemli-Opitz syndrome
Tay-Sachs disease
Fabry disease
5-alpha-reductase deficiency
Cystic fibrosis
X-linked adrenoleukodystrophy
Metachromatic leukodystrophy
Glutaric acidemia type II
Spinal muscular atrophy with respiratory distress type 1
Niemann-Pick disease
Primary carnitine deficiency
Autosomal recessive polycystic kidney disease
Hemophilia A
Hemophilia B



Benefits of GEN28 carrier screening
The GEN28 test offers significant benefits for families. If no disease-carrying gene is detected, couples can confidently plan for pregnancy with minimal concern about genetic risks. If only one partner is a carrier, detailed genetic counseling will be provided, along with an appropriate monitoring plan to ensure a safe pregnancy. When both partners carry the same disease gene, GEN28 enables couples to proactively choose safe reproductive options and effectively prevent disease transmission to their children. For families with a history of genetic disorders, the test helps identify disease-causing genes and provides genetic counseling to minimize hereditary risks for future generations.
With GEN28 by Eurofins GENTIS, healthcare planning becomes more proactive and reassuring. The test enables early detection of recessive genetic carriers, assesses the risk of disease transmission to offspring, and supports couples in making safe and informed reproductive decisions. In addition, GEN28 is accompanied by personalized genetic counseling services, delivering accurate information and practical guidance—helping families fully understand their genetic health and prepare for a healthier future for their children.


            [content_more] => 
            [meta_title] => Eurofins GENTIS launches GEN28 – carrier screening test for 28 recessive genetic disorders
            [meta_description] => On the journey of parenthood, nothing is more important than ensuring a child is born healthy. In reality, many individuals who appear completely healthy may unknowingly carry recessive genetic mutations. When both partners carry the same recessive gene, 
            [meta_keyword] => GENTIS,GEN28
            [thumbnail_alt] => 
            [post_id] => 1399
            [category_id] => 4
        )

    [7] => stdClass Object
        (
            [id] => 1398
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 605764480_1275897227908799_5804145375518154194_n.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-12-29
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-12-29 08:29:14
            [updated_time] => 2026-01-15 09:52:40
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Congratulations-on-the-successful-December-prenatal-class-The-journey-to-happy-motherhood-of-Andrology-and-Fertility-hospital-of-Hanoi
            [title] => Congratulations on the successful December prenatal class – The journey to happy motherhood of Andrology and Fertility hospital of Hanoi
            [description] => On the morning of December 27, 2025, at the 5th Floor Hall – Building A, Andrology and Fertility hospital of Hanoi, the program “Prenatal Class – The Journey to Happy Motherhood” was successfully held, leaving many deep emotions and meaningful values for all expectant mothers and their families in attendance. The program was not only a simple medical knowledge-sharing session but also a journey of spreading love, understanding, and strong faith for families preparing to welcome their little angels.
            [content] => 
Prenatal class – A strong foundation for the journey of motherhood
Pregnancy and childbirth are sacred journeys, yet they are also accompanied by many worries and concerns, especially for first-time mothers or families who have experienced the long and challenging journey of infertility. Understanding this, Hanoi Andrology and Fertility Hospital, in collaboration with the Happy Home Association, organized the Prenatal Class – The Journey to Happy Motherhood with the hope of providing expectant mothers with scientific knowledge, emotional stability, and the most comprehensive preparation before their delivery day.

From early morning, the hall welcomed a large number of expectant mothers and their families, creating a warm, intimate atmosphere filled with positive energy. The enthusiastic participation of families clearly reflected the strong demand for systematic prenatal education and the trust they place in the hospital’s medical team.
Experienced doctors accompanying Parents-to-be
The program was honored to have the direct participation and sharing of experienced obstetrics and gynecology specialists from Hanoi Andrology and Fertility Hospital:
 Dr. Nguyen Thi Hong Nhung, Specialist in Obstetrics and Gynecology, and Dr. Dam Dinh Tam, Specialist in Obstetrics and Gynecology.

With solid professional expertise and years of experience accompanying thousands of childbirth cases, the doctors delivered practical, easy-to-understand, and highly relevant information. The class focused on key concerns such as physical changes during pregnancy, signs of labor, natural birth and cesarean section procedures, pain management during labor, postpartum care for both mother and baby, as well as psychological preparation for welcoming the newborn.
Beyond one-way knowledge sharing, the doctors devoted significant time to directly answering every question from expectant mothers and their families — from simple concerns about nutrition and safe exercise to deeper worries about the childbirth process — all were carefully listened to and thoroughly advised.
Providing official medical knowledge – Confidence for a safe delivery
One of the most outstanding values of the prenatal class was the provision of official medical knowledge based on professional guidelines and clinical practice. This helped expectant mothers avoid misleading and unverified information widely circulating on social media.

Through the class, mothers gained a better understanding of their own bodies, learned how to listen to changes during pregnancy, and recognized early signs that require medical attention. More importantly, with sufficient knowledge and strong psychological preparation, mothers felt much more confident and reassured when approaching childbirth — a sacred and unforgettable milestone in life.
Many participants shared that after the session, they felt more relaxed, less anxious, and more confident about the journey ahead. This is precisely the goal Hanoi Andrology and Fertility Hospital always strives for when organizing its regular prenatal classes.
A loving connection space for the whole family
Not only for expectant mothers, the prenatal class also created an opportunity for future fathers and family members to join, listen, and better understand the journey of pregnancy and childbirth. Family support is a powerful source of emotional strength, helping mothers feel more secure and happy.

The class atmosphere was open and friendly, where everyone could share their own stories, emotions, and experiences. This meaningful connection helped form a warm community where families prepared for parenthood with a proactive and positive mindset.
Eurofins GENTIS – Proud to be the accompanying sponsor
Contributing significantly to the success of the program, Eurofins GENTIS was honored to be the accompanying sponsor of the Prenatal Class – The Journey to Happy Motherhood. With the mission of providing high-quality testing solutions and healthcare services, Eurofins GENTIS continuously supports Vietnamese families in achieving safe and healthy pregnancies and childbirth.
Their companionship not only ensured a well-organized and meaningful program but also reflected a long-term commitment to maternal and child healthcare, especially during the prenatal stage — the foundation for a child’s comprehensive development in the future.
In the coming time, Eurofins GENTIS will continue accompanying the regular prenatal classes of Hanoi Andrology and Fertility Hospital, contributing to the best possible physical and emotional preparation for expectant mothers before childbirth. Because Eurofins GENTIS understands that each class is not just a knowledge-sharing session, but also a meaningful milestone that builds mothers’ confidence, strengthens family bonds, and makes the journey of parenthood gentler and happier.
The Prenatal Class – The Journey to Happy Motherhood on December 27, 2025 concluded in a warm atmosphere filled with joy and trust. The success of the program once again affirms the continuous efforts of Hanoi Andrology and Fertility Hospital in providing comprehensive care for families, along with the valuable support of partners such as Eurofins GENTIS.
We wish all expectant mothers good health, peace of mind, a fulfilling pregnancy, and a smooth, gentle delivery. May all families soon welcome their beloved babies, opening a new chapter filled with happiness and love.

            [content_more] => 
            [meta_title] => Congratulations on the successful December prenatal class – The journey to happy motherhood of Andro
            [meta_description] => On the morning of December 27, 2025, at the 5th Floor Hall – Building A, Andrology and Fertility hospital of Hanoi, the program “Prenatal Class – The Journey to Happy Motherhood” was successfully held, leaving many deep emotions and meaningful values for 
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1398
            [category_id] => 4
        )

)